【摘要】 目的 了解2007年-2008年成都地區17家醫院抗腫瘤藥物的使用情況。 方法 以銷售金額、用藥頻度（DDDs）對2007年、2008年成都地區17家醫院抗腫瘤藥物消耗數據進行分類統計、綜合分析、對比。 結果 2008年成都地區17家醫院抗腫瘤藥物用藥金額增長幅度較大，各亞類抗腫瘤藥物中其它類抗腫瘤藥物類、植物來源的抗腫瘤藥、抗代謝藥金額排序依次占前3位。銷售金額前100位藥物中，腫瘤藥物占據8位，大多數是其它類抗腫瘤藥物，且其用藥頻度也靠前。 結論 抗腫瘤藥物用藥金額和用藥量都將快速增長，其中其它類抗腫瘤藥物和植物來源的抗腫瘤藥的發展尤被看好。
【Abstract】 Objective To evaluate the situation of antineoplastics used in Chengdu area from 2007 to 2008. Methods The consumption data of antineoplastics used in 17 hospitals of Chengdu area in 2007 and 2008 were classified, and the consumption sum and defined daily doses (DDDs) were analyzed. Results The total consumption sum of antineoplastics in 2008 increased sharply. Other antineoplastics, herbal-sourced antineoplastics and antimetabolism drugs ranked in the first three places. Among the top drugs in terms of consumption sum, antineoplastics took 8 places. Conclusion The consumption sum and DDDs of antineoplastics, especially other antineoplastics and herbal-sourced antineoplastics, will increase rapidly.
Citation： ZHAO Yujin,LIU Kexin,TANG Yao. Analysis of Use of Antineoplastics in 17 Hospitals of Chengdu Area from 2007 to 2008. West China Medical Journal, 2010, 25(7): 1322-1324. doi: Copy
Copyright ? the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved